SCHEMBL27435494

SCHEMBL27435494

COc1c(Cl)cc2c(c1C(=O)O)OCCN2CCCc1nccs1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90B1 P14625 1/20 0.33
CYP3A4 P08684 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 1/20 0.32
TSHR P16473 2/20 0.31
MAPK1 P28482 1/20 0.31
DRD3 P35462 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
BCL2 P10415 1/20 0.31
MCL1 Q07820 1/20 0.31
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
SPR P35270 1/20 0.30
CTSA P10619 1/20 0.30
CYSLTR2 Q9NS75 1/20 0.30
CYSLTR1 Q9Y271 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954078 1.00 GRM5 (0.33) GRM5HSP90AA1HSP90B1CYP3A4HTR2C
SCHEMBL27435477 0.92 HSP90B1 (0.40) GRM5HSP90AA1HSP90B1CYP3A4HTR2C
SCHEMBL30954041 0.89 CYP3A4 (0.38) GRM5HSP90AA1HSP90B1CYP3A4HTR2C
SCHEMBL27435450 0.89 CYP3A4 (0.38) GRM5HSP90AA1HSP90B1CYP3A4HTR2C
SCHEMBL27435439 0.81 HSP90B1 (0.44) GRM5HSP90AA1HSP90B1CYP3A4HTR2C
SCHEMBL30954074 0.79 MAPT (0.36) TSHRMAPK1DRD3KDM4EALDH1A1
SCHEMBL27434942 0.79 MAPT (0.36) TSHRMAPK1DRD3KDM4EALDH1A1
SCHEMBL30954160 0.78 KDM4E (0.40) CYP3A4HTR2CMAPK1DRD3KDM4E
SCHEMBL27435335 0.78 KDM4E (0.40) CYP3A4HTR2CMAPK1DRD3KDM4E
SCHEMBL30954054 0.78 KCNA3 (0.43) TSHRMAPK1DRD3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed